Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

UnitedHealth Group

Large pharmacy benefit managers and their pricing practices are falling under increasing regulatory scrutiny.

Supreme Court to Tackle PBM Regulations and How Much They Can Charge

Humana

Walmart

From venture-backed start-ups to drug store retailers, there is a big push this year to use technology and data to supercharge the less glamorous side of the industry -- physician-centered primary care.

Health-care companies use technology and data to boost primary care services

AmerisourceBergen

Cardinal Health

Johnson & Johnson

McKesson

Rite Aid

Teva Pharmaceutical

Walgreens

Several companies might have to pay out $48 billion or more.

Multi-Billion Dollar Opioid Litigation Targets Drug Companies, Drugstores, and Maybe Doctors

The drugstores allege it was the doctors who prescribed the pills who should shoulder the culpability for the opioid crisis.

CVS, Walgreens, And Rite Aid Sue Doctors In Latest Move In Federal Opioid Case

Apple

Disney

Duke Energy

Microsoft

While most analysts say 2020 is set to deliver another year of gains, concerns about the economy persist.

5 Stocks to Consider for the New Year

Beaten-down pharmacy chain stocks could enter new uptrends in the coming months.

Pharmacy Chains Could Reward Bottom Fishers in 2020

CVS Health (NYSE: CVS) is the largest pharmacy services provider in the US comprising of the largest network of retail pharmacy stores nationwide along with pharmacy services and claims processing. The company’s pharmacy business, which makes revenues by sales of prescription drugs and.

What Are CVS Health’s Key Sources of Revenue?

DuPont de Nemours

General Dynamics

Texas Instruments

The S&P Dow Jones Indices must be more proactive to protect investors from getting confused.

Remove Boeing, Walgreens, Dow And UTD From The DJIA And Replace Them With These 4 Stocks

CVS Health (NYSE: CVS) spent $146 billion in cost of goods sold expenses in 2016, and the figure increased to $156 billion in 2018, driven by growth in revenues. As a percentage of revenue, COGS declined from 83% in 2016 to 80% in 2018.

How Large Is Cost of Goods Sold Expense For CVS Health?

Moving To The Sidelines On CVS Health Corporation

Aphria

Baidu

Costco

NVIDIA

Tanger Factory Outlet Centers

AT&T

Visa

Exxon Mobil

2020 is likely to offer investors more volatility, but these 10 stocks look poised to deliver over the next 12 months.
The post 10 Best Stocks to Beat the Market in 2020 appeared first on InvestorPlace.

10 Best Stocks to Beat the Market in 2020

Ascena Retail Group

Bed Bath & Beyond

Chico's FAS

Destination Maternity

FRED'S

GameStop

Gap Inc

Landbridge Co LLC

Pier 1 Imports

Party City Holdco

"Sears, Payless ShoeSource, Forever 21 and Walgreens are among the retailers that announced store closures in 2019, a record year according to Coresight Research. "

Retailers announced record store closures in 2019. Here's a list

Becton, Dickinson and Co.

Becton Dickinson & Co. Deposit Repr 1/20th Cum Conv Pfd Registered Series A

Chevron

FedEx

Lowe's

Valmont Industries

Investment pro Michael Farr unveils his top 10 stock picks for 2020

Michael Farr's top 10 stock picks for 2020

Both pharmacy retail giants are focusing on new strategies to win over consumers, but which stock is the better investment today?

Better Buy:  CVS vs. Walgreens Boots Alliance

Amazon

LHC Group

Livongo Health Inc

Teladoc

These companies could see their sales soar as seniors increasingly choose to live in their homes longer.

How to Profit From the Massive Aging-in-Place Healthcare Trend

CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.

CVS Health Rides on Aetna Prospects, Strong Selling Season

California is slapping CVS with a $3.6 million fine for not following state recycling laws.

CVS fined for not following California's recycling laws

The healthcare company has enjoyed six excellent months, but there are reasons to believe more good times are yet to come.

CVS Health Still Has Room to Run

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?

CVS Health's Larry Merlo voices his concerns over the teen vaping crisis and the longterm health risks.

CVS CEO: I saw Hello Kitty logo on a vaping device 5 years ago and knew something was wrong

A strong earnings report and interest from an activist investor helped lift the stock.

Why CVS Health Stock Gained 13% Last Month

Centene

CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.

CVS Health Set to Acquire Centene's IlliniCare Health Plan

Despite strong quarterly results, there is likely to be short-term profit-taking in CVS stock.
The post Should You Ring the Cash Register with CVS Stock In December?

Should You Ring the Cash Register with CVS Stock In December?

News for CVS Health Stock (CVS)